Clinical and Experimental Vaccine Research

  • 제11권1호
  • /
  • Pages.89-95
  • /
  • 2022
  • /
  • 2287-3651(pISSN)
  • /
  • 2287-366X(eISSN)
대한백신학회 (The Korean Vaccine Society)
권호 표지
DOI QR코드

DOI QR Code

Factors associated with side effects of COVID-19 vaccine in Indonesia

  • 투고 : 2021.07.23
  • 심사 : 2021.12.15
  • 발행 : 2022.01.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: As coronavirus disease 2019 (COVID-19) continues to spread rapidly causing approximately 186 million confirmed cases around the world, the urgency to reach herd immunity through vaccination is increasing. However, vaccine safety is a top priority to limit the occurrence of adverse events. Henceforth, this study aims to recognize and perceive COVID-19 vaccine safety in Indonesia during the pandemic. Materials and Methods: This is a cross-sectional study and was conducted in Indonesia during the COVID-19 pandemic using an online survey of demographic information and a qualitative questionnaire. Responses were recorded and the association between demographic characteristics from survey questions was tested using chi-square with a risk estimate and 95% confidence interval. Results: A total of 311 participants from 33 out of 34 provinces in Indonesia participated in this study. Recorded responses showed multiple side effects of the COVID-19 vaccine both short-and long-term experienced by the participants. Significant associations were found between demographic factors and COVID-19 vaccine side effects such as female gender with short-term puncture site (odds ratio [OR], 0.463; 95% confidence interval [CI], 0.263-0.816) and short-term other reactions (OR, 0.463; 95% CI, 0.263-0.816), domicile outside Java island with long-term puncture site (OR, 4.219; 95% CI, 1.401-12.701) and immune reactions (OR, 3.375; 95% CI, 1.356-8.398), also between married marital status and long-term vagal reaction (OR, 4.655; 95% CI, 1.321-16.409). Conclusion: Gender, domicile and marital status factors were associated with COVID-19 vaccine side effects in Indonesian people.

키워드

참고문헌

  1. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing; 2021.
  2. World Health Organization. WHO coronavirus (COVID-19) dashboard: WHO coronavirus (COVID-19) dashboard with vaccination data [Internet]. Geneva: World Health Organization; 2021 [cited 2021 Jun 20]. Available from: https://covid19.who.int/.
  3. Spiteri G, Fielding J, Diercke M, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill 2020;25:2000178.
  4. Center for Strategic and International Studies. Southeast Asia COVID-19 Tracker [Internet]. Washington (DC): Center for Strategic and International Studies; 2021 [cited 2021 Jun 20]. Available from: https://www.csis.org/programs/southeast-asia-program/projects/southeast-asia-covid19-tracker.
  5. Covid19.go.id. Peta Sebaran [Internet]. [place unknown]: Covid19.go.id; 2021 [cited 2021 Jun 20]. Available from: https://covid19.go.id/peta-sebaran.
  6. Kaur SP, Gupta V. COVID-19 Vaccine: a comprehensive status report. Virus Res 2020;288:198114.
  7. Mathieu E, Ritchie H, Ortiz-Ospina E, et al. A global database of COVID-19 vaccinations. Nat Hum Behav 2021;5:947-53.
  8. Centers for Disease Control and Prevention. Possible side effects after getting a COVID-19 vaccine [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2021 [cited 2021 Jun 20]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html.
  9. World Health Organization. Coronavirus disease (COVID-19): vaccines safety [Internet]. Geneva: World Health Organization; 2021 [cited 2021 Jun 20]. Available from: https://www.who.int/news-room/q-a-detail/coronavirusdisease-(covid-19)-vaccines-safety.
  10. Kostoff RN, Briggs MB, Porter AL, Spandidos DA, Tsatsakis A. [Comment] COVID-19 vaccine safety. Int J Mol Med 2020;46:1599-602.
  11. Kaur RJ, Dutta S, Bhardwaj P, et al. Adverse events reported from COVID-19 vaccine trials: a systematic review. Indian J Clin Biochem 2021;36:1-13.
  12. World Health Organization. WHO provides one million antigen-detecting rapid diagnostic test kits to accelerate COVID-19 testing in Indonesia [Internet]. Geneva: World Health Organization; 2021 [cited 2021 Jun 20]. Available from: https://www.who.int/indonesia/news/detail/17-03-2021-who-provides-one-million-antigen-detectingrapid-diagnostic-test-kits-to-accelerate-covid-19-testingin-indonesia.
  13. Adella Halim D, Kurniawan A, Agung FH, et al. Understanding of young people about COVID-19 during early outbreak in Indonesia. Asia Pac J Public Health 2020;32:363-5.
  14. Centers for Disease Control and Prevention. When you've been fully vaccinated [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2021 [cited 2021 Jun 20]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated.html.
  15. Rizki SA, Kurniawan J, Budimulia P, et al. Knowledge, attitude, and practice in indonesian health care workers regarding COVID-19. Asia Pac J Public Health 2021;33:662-4.